Delivery Order SPE2DR25D7010-SPE2DR26FX8RX
Award Date 3/19/26
Potential Completion Date 3/20/26
Potential Value $3.3K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $12,682.88 delivery order to Amerisourcebergen Drug Corp on March 20, 2026, for 100 mg vials of Activase, with an ultimate completion date of March 23, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside.</p>
- <p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 18, 2026, for Activase 100 mg vials with a ceiling value of $11,465.00.</p> <p>Place of performance is Conshohocken, PA. The order carries an ultimate completion date of February 19, 2026, and is priced on a firm fixed-price basis. No set-aside was used for this order.</p>
- <p>The Defense Logistics Agency issued a $15,516.21 delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Activase 50 mg injection under a firm fixed-price arrangement. Ultimate completion date is March 3, 2026. Place of performance is Conshohocken, PA.</p>
- <p>The Defense Logistics Agency issued a $11,607.70 delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for ACTIVASE 100 mg vials with an ultimate completion date of February 26, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is priced firm fixed price with no set-aside applied.</p>
- <p>The Defense Logistics Agency issued a $21,691.02 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for ACTIVASE 50 MG vials, with ultimate completion on February 25, 2026.</p> <p>The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside used.</p>
- The Defense Logistics Agency awarded a delivery order valued at $6,237.63 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Activase 100 mg vials, with an ultimate completion date of November 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 50 mg vials of Activase on August 20, 2025, with a contract ceiling value of $3,662.41. This firm fixed-price delivery order, which carries an ultimate completion date of August 21, 2025, represents a competitively awarded non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is executed under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $38,853.47 to Amerisourcebergen Drug Corporation to supply 4561425706 units of 50 mg vials of the drug Activase. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 7-10, 2023. This delivery order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to support the medical...
- The Defense Logistics Agency issued a $35,987.68 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for ACTIVASE 100 MG vials, with final delivery due February 6, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. Pricing is firm fixed...
- The Defense Logistics Agency awarded a $33,311.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Activase 100 mg vials, with performance completion targeted for October 29, 2025. The award, issued without a set-aside designation, reflects open competitive procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- SPE2DR25D7010Indefinite Delivery Contract
- SPE2DR25D7010-SPE2DR26FX8RXDelivery Order
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 19, 2026, for 50 mg vials of Activase with a ceiling value of $3,294.77, under firm fixed-price terms. Place of performance is Conshohocken, PA. The order is scheduled for ultimate completion on March 20, 2026. No set-aside was used.
Generated 6/18/26, 9:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 3/18/26 |